Jay Keasling, JBEI CEO presents at the AAAS Annual Meeting
One of the topics presented at the AAAS meeting was alternative fuels. This sessesion was led by the Lab’s Associate Laboratory Director for Biosciences, and JBEI CEO, Jay Keasling, who looked at the possibility of using synthetic biology to create advanced biofuels. Joining Keasling on the panel was the Lab’s Michelle Chang.
Read the LBL Article >
Alexandra Krawicz, JCAP Postdoc working with PBD PI Gary Moore receives Presentation award
Alexandra Krawicz — a postdoctoral researcher at the Joint Center for Artificial Photosynthesis working with Physical Biosciences Division principal investigator Gary F. Moore — was acknowledged for her contributions to the field of Artificial Photosynthesis at the 23rd Western Photosynthesis Conference held in Pacific Grove, CA. Her presentation at the meeting, “Structure, Energetics and Efficiency Analysis of a Cobaloxime Modified Photocathode” described work recently published with coauthor Diana Cedeno and corresponding author Gary F. Moore in the journal Physical Chemistry Chemical Physics. The research provides an energetics and efficiency analysis of a material capable of harnessing solar energy into fuel. Read More >
JBEI Prototype Inventions
Researchers from the Joint BioEnergy Institute, Joint Genome Institute, and collaborators have developed a portable, network-enabled system for testing drinking water contamination. The system, called ScanDrop, uses microfluidics technology and cloud-based networking to scan water samples for pathogens and transmit the data remotely.
Read More >
Seung-Wuk Lee's Research
Some may think of turkeys as good for just lunch meat and holiday meals, but bioengineers at UC Berkeley saw inspiration in the big birds for a new type of biosensor that changes color when exposed to chemical vapors. This feature makes the sensors valuable detectors of toxins or airborne pathogens. Read More >
New Insight into an Emerging Genome-Editing Tool
The potential is there for bacteria and other microbes to be genetically engineered to perform a cornucopia of valuable goods and services, from the production of safer, more effective medicines and clean, green, sustainable fuels, to the clean-up and restoration of our air, water and land. Cells from eukaryotic organisms can also be modified for research or to fight disease. To achieve these and other worthy goals, the ability to precisely edit the instructions contained within a target’s genome is a must. A powerful new tool for genome editing and gene regulation has emerged in the form of a family of enzymes known as Cas9, which plays a critical role in the bacterial immune system. Read the LBL Article Here>